Dentists in Oak Island, NC Accepting Medicare
3 Dentists found. Showing 1 - 3
 Dr. Darren W Harrington, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 8212 E Oak Island Dr, Oak Island, NC 28465 Phone: 910-457-0626 Fax: 910-278-3305 |
Dr. Robert Aaron Wilharm, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 8212 E Oak Island Dr, Oak Island, NC 28465 Phone: 910-278-3268 |
Dr. Matthew Keith Miller, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 8212 E Oak Island Dr, Oak Island, NC 28465 Phone: 910-278-3268 Fax: 910-278-3305 |
News Archive
Air filtration device removes almost all traces of airborne SARS-CoV-2
When a team of doctors, scientists and engineers at Addenbrooke's Hospital and the University of Cambridge placed an air filtration machine in COVID-19 wards, they found that it removed almost all traces of airborne SARS-CoV-2.
Call for an Australian crackdown on complementary and alternative medicines
A team of Australian researchers says there is an urgent need for the overhaul of the regulation of complementary medicines.
Mylan confirms first-to-file patent challenge of AMRIX capsules
Mylan Inc. has confirmed that the company and its subsidiary, Mylan Pharmaceuticals Inc., have been sued by Cephalon Inc., Eurand Inc. and Anesta AG in connection with the filing of an Abbreviated New Drug Application (ANDA) for Cyclobenzaprine Hydrochloride (HCl) Extended-release (ER) Capsules, 15 mg and 30 mg, the generic version of AMRIX Capsules.
People increasingly using Reddit to 'diagnose' STDs
A new study reveals that people are sharing images of their genitalia on social media in the hope of getting their sexually transmitted infections (STIs) diagnosed by others. This disturbing news not only points at rise in STIs but also misconceptions and lack of motivation to seek authentic medical advice say researchers. The study was published this week in the latest issue of the Journal of American Medical Association (JAMA).
Single shared REMS for TIRF products receives FDA approval
The U.S. Food and Drug Administration today approved a single shared Risk Evaluation and Mitigation Strategy (REMS) for the transmucosal immediate-release fentanyl (TIRF) products. This new shared system will replace the individual REMS and allow prescribers and pharmacies to enroll into just one system, easing the burden on the health care system.
› Verified 9 days ago
Dentists
Counselors
Psychologists
Pharmacists
Clinical Social Workers